SCNI Stock Analysis: Buy, Sell, or Hold?
SCNI - Scinai Immunotherapeutics Ltd. American Depositary Shares
$0.26
-0.01 (-4.06%)
▼
5d:
-4.13%
30d:
-41.25%
90d:
-57.72%
BUY
HIGH Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Jul 01, 2026
0d
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SCNI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SCNI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $0.26, which is considered oversold relative to its 30-day fair value range of $0.26 to $0.41.
Technical Outlook: Technically, SCNI is in a strong downtrend. The price is currently testing key support at $0.34. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $700.00 (+271323.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SCNI is in a strong downtrend. The price is currently testing key support at $0.34. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $700.00 (+271323.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.26 -
$0.41
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 271323.0% below Wall St target ($700.00)
Trading Range Analysis
30-Day Trading Range
$0.26 -
$0.41
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.34
Resistance Level
$0.50
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$700.00
(+271323.0%)
Revenue Growth (YoY)
-16.6%
Earnings Growth (YoY)
87.2%
Profit Margin
-261.4%
Share & Embed Analysis
Last updated: July 07, 2026 10:51 PM ET
Data refreshes hourly during market hours. Next update: 11:51 PM
Data refreshes hourly during market hours. Next update: 11:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$435 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 57 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 60 BUY |